 | • レポートコード：QY2108PAL8879 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、146ページ • 納品方法：Eメール（納期：1日） • 産業分類：医薬品 |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の当調査資料ではグローバルにおけるリポソームドラッグデリバリーの市場規模（2016年-2027年）と動向についてまとめました。中国市場については主要プレイヤーの市場シェア、リポソームドラッグデリバリーの種類別市場規模（リポソームドキソルビシン、リポソームアンホテラシンB、リポソームパクリタキセル、その他）、用途別市場規模（真菌感染症治療、がん・腫瘍治療、その他）も掲載しています。他に、北米・アメリカ市場、ヨーロッパ市場、アジア太平洋・日本市場、中南米市場、中東・アフリカ市場の市場規模、グローバル市場機会・課題・リスク要因、バリューチェーン・販売チャネル、主要プレイヤーの情報なども掲載しています。 ・調査の概要 ・調査のサマリー ・世界のリポソームドラッグデリバリー市場動向 ・グローバル主要プレイヤーの競争状況・市場シェア ・世界におけるリポソームドラッグデリバリーの種類別市場規模（2016年-2027年）：リポソームドキソルビシン、リポソームアンホテラシンB、リポソームパクリタキセル、その他 ・世界におけるリポソームドラッグデリバリーの用途別市場規模（2016年-2027年）：真菌感染症治療、がん・腫瘍治療、その他 ・リポソームドラッグデリバリーの中国市場分析 - リポソームドラッグデリバリーの中国市場規模（2016年-2027年） - 中国におけるリポソームドラッグデリバリーの主要プレイヤー別市場シェア - 中国におけるリポソームドラッグデリバリーの種類別市場規模：リポソームドキソルビシン、リポソームアンホテラシンB、リポソームパクリタキセル、その他 - 中国におけるリポソームドラッグデリバリーの用途別市場規模：真菌感染症治療、がん・腫瘍治療、その他 ・リポソームドラッグデリバリーの北米市場（2016年-2027年） ・リポソームドラッグデリバリーのヨーロッパ市場（2016年-2027年） ・リポソームドラッグデリバリーのアジア太平洋市場（2016年-2027年） ・リポソームドラッグデリバリーの中南米市場（2016年-2027年） ・リポソームドラッグデリバリーの中東・アフリカ市場（2016年-2027年） ・主要プレイヤーの情報：Johnson & Johnson、Gilead Sciences、Pacira、Sun Pharmaceutical、Luye Pharma、Sigma-Tau Group、Fudan-Zhangjiang、Teva Pharmaceutical、CSPC、Novartis、Kingond Pharm、Spectrum Pharmaceuticals、Shanghai New Asia ・市場機会・課題・リスク要因分析 ・バリューチェーン・販売チャネル分析 ・... |
Liposomes have been used to improve the therapeutic index of new or established drugs by modifying drug absorption, reducing metabolism, prolonging biological half-life or reducing toxicity. Drug distribution is then controlled primarily by properties of the carrier and no longer by physico-chemical characteristics of the drug substance only.
In a liposome drug product, the drug substance is contained in liposomes. Typically, water soluble drugs are contained in the aqueous compartment(s) and hydrophobic drugs are contained in the lipid layer(s) of the liposomes. Release of drugs from liposome formulations can be modified by the presence of polyethylene glycol and/or cholesterol or other potential additives in the liposome.
North America dominated the market with market share of 44% due to the high medical level. Following North America, Europe is the second largest market with market share of 36%. Asian Pacific regions are the third largest market with developed countries like Japan and many developing countries like China. Its market share is about 12%.
Johnson & Johnson, Gilead Sciences, Pacira, Sun Pharmaceutical, Luye Pharma and Sigma-Tau Group are the top 6 players of Liposomes Drug Delivery, with about 77% market shares.
Market Analysis and Insights: Global and China Liposomes Drug Delivery Market
This report focuses on global and China Liposomes Drug Delivery market.
In 2020, the global Liposomes Drug Delivery market size was US$ 3087.7 million and it is expected to reach US$ 5921.5 million by the end of 2027, with a CAGR of 10.0% during 2021-2027. In China the Liposomes Drug Delivery market size is expected to grow from US$ XX million in 2020 to US$ XX million by 2027, at a CAGR of XX% during the forecast period.
Global Liposomes Drug Delivery Scope and Market Size
Liposomes Drug Delivery market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Liposomes Drug Delivery market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2016-2027.
For China market, this report focuses on the Liposomes Drug Delivery market size by players, by Type, and by Application, for the period 2016-2027. The key players include the global and local players which play important roles in China.
Segment by Type
Liposomal Doxorubicin
Liposomal Amphoteracin B
Liposomal Paclitaxel
Others
Segment by Application
Fungal Infection Therapy
Cancer & Tumor Therapy
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
By Company
Johnson & Johnson
Gilead Sciences
Pacira
Sun Pharmaceutical
Luye Pharma
Sigma-Tau Group
Fudan-Zhangjiang
Teva Pharmaceutical
CSPC
Novartis
Kingond Pharm
Spectrum Pharmaceuticals
Shanghai New Asia
1 Study Coverage
1.1 Liposomes Drug Delivery Product Introduction
1.2 Market by Type
1.2.1 Global Liposomes Drug Delivery Market Size Growth Rate by Type
1.2.2 Liposomal Doxorubicin
1.2.3 Liposomal Amphoteracin B
1.2.4 Liposomal Paclitaxel
1.2.5 Others
1.3 Market by Application
1.3.1 Global Liposomes Drug Delivery Market Size Growth Rate by Application
1.3.2 Fungal Infection Therapy
1.3.3 Cancer & Tumor Therapy
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Liposomes Drug Delivery Market Size, Estimates and Forecasts
2.1.1 Global Liposomes Drug Delivery Revenue 2016-2027
2.1.2 Global Liposomes Drug Delivery Sales 2016-2027
2.2 Global Liposomes Drug Delivery, Market Size by Region: 2016 VS 2021 VS 2027
2.3 Liposomes Drug Delivery Historical Market Size by Region (2016-2021)
2.3.1 Global Liposomes Drug Delivery Retrospective Market Scenario in Sales by Region: 2016-2021
2.3.2 Global Liposomes Drug Delivery Retrospective Market Scenario in Revenue by Region: 2016-2021
2.4 Liposomes Drug Delivery Market Estimates and Projections by Region (2022-2027)
2.4.1 Global Liposomes Drug Delivery Sales Forecast by Region (2022-2027)
2.4.2 Global Liposomes Drug Delivery Revenue Forecast by Region (2022-2027)
3 Global Liposomes Drug Delivery Competitor Landscape by Players
3.1 Global Top Liposomes Drug Delivery Manufacturers by Sales
3.1.1 Global Liposomes Drug Delivery Sales by Manufacturer (2016-2021)
3.1.2 Global Liposomes Drug Delivery Sales Market Share by Manufacturer (2016-2021)
3.2 Global Top Liposomes Drug Delivery Manufacturers by Revenue
3.2.1 Key Liposomes Drug Delivery Manufacturers Covered: Ranking by Revenue
3.2.2 Global Liposomes Drug Delivery Revenue by Manufacturers (2016-2021)
3.2.3 Global Liposomes Drug Delivery Revenue Share by Manufacturers (2016-2021)
3.2.4 Global Liposomes Drug Delivery Market Concentration Ratio (CR5 and HHI) (2016-2021)
3.2.5 Global Top 10 and Top 5 Companies by Liposomes Drug Delivery Revenue in 2020
3.2.6 Global Liposomes Drug Delivery Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Liposomes Drug Delivery Price by Manufacturers
3.4 Global Liposomes Drug Delivery Manufacturing Base Distribution, Product Types
3.4.1 Liposomes Drug Delivery Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Liposomes Drug Delivery Product Type
3.4.3 Date of International Manufacturers Enter into Liposomes Drug Delivery Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2016-2027)
4.1 Global Liposomes Drug Delivery Market Size by Type (2016-2021)
4.1.1 Global Liposomes Drug Delivery Sales by Type (2016-2021)
4.1.2 Global Liposomes Drug Delivery Revenue by Type (2016-2021)
4.1.3 Liposomes Drug Delivery Average Selling Price (ASP) by Type (2016-2021)
4.2 Global Liposomes Drug Delivery Market Size Forecast by Type (2022-2027)
4.2.1 Global Liposomes Drug Delivery Sales Forecast by Type (2022-2027)
4.2.2 Global Liposomes Drug Delivery Revenue Forecast by Type (2022-2027)
4.2.3 Liposomes Drug Delivery Average Selling Price (ASP) Forecast by Type (2022-2027)
5 Breakdown Data by Application (2016-2027)
5.1 Global Liposomes Drug Delivery Market Size by Application (2016-2021)
5.1.1 Global Liposomes Drug Delivery Sales by Application (2016-2021)
5.1.2 Global Liposomes Drug Delivery Revenue by Application (2016-2021)
5.1.3 Liposomes Drug Delivery Price by Application (2016-2021)
5.2 Liposomes Drug Delivery Market Size Forecast by Application (2022-2027)
5.2.1 Global Liposomes Drug Delivery Sales Forecast by Application (2022-2027)
5.2.2 Global Liposomes Drug Delivery Revenue Forecast by Application (2022-2027)
5.2.3 Global Liposomes Drug Delivery Price Forecast by Application (2022-2027)
6 China by Players, Type and Application
6.1 China Liposomes Drug Delivery Market Size YoY Growth 2016-2027
6.1.1 China Liposomes Drug Delivery Sales YoY Growth 2016-2027
6.1.2 China Liposomes Drug Delivery Revenue YoY Growth 2016-2027
6.1.3 China Liposomes Drug Delivery Market Share in Global Market 2016-2027
6.2 China Liposomes Drug Delivery Market Size by Players (International and Local Players)
6.2.1 China Top Liposomes Drug Delivery Players by Sales (2016-2021)
6.2.2 China Top Liposomes Drug Delivery Players by Revenue (2016-2021)
6.3 China Liposomes Drug Delivery Historic Market Review by Type (2016-2021)
6.3.1 China Liposomes Drug Delivery Sales Market Share by Type (2016-2021)
6.3.2 China Liposomes Drug Delivery Revenue Market Share by Type (2016-2021)
6.3.3 China Liposomes Drug Delivery Price by Type (2016-2021)
6.4 China Liposomes Drug Delivery Market Estimates and Forecasts by Type (2022-2027)
6.4.1 China Liposomes Drug Delivery Sales Forecast by Type (2022-2027)
6.4.2 China Liposomes Drug Delivery Revenue Forecast by Type (2022-2027)
6.4.3 China Liposomes Drug Delivery Price Forecast by Type (2022-2027)
6.5 China Liposomes Drug Delivery Historic Market Review by Application (2016-2021)
6.5.1 China Liposomes Drug Delivery Sales Market Share by Application (2016-2021)
6.5.2 China Liposomes Drug Delivery Revenue Market Share by Application (2016-2021)
6.5.3 China Liposomes Drug Delivery Price by Application (2016-2021)
6.6 China Liposomes Drug Delivery Market Estimates and Forecasts by Application (2022-2027)
6.6.1 China Liposomes Drug Delivery Sales Forecast by Application (2022-2027)
6.6.2 China Liposomes Drug Delivery Revenue Forecast by Application (2022-2027)
6.6.3 China Liposomes Drug Delivery Price Forecast by Application (2022-2027)
7 North America
7.1 North America Liposomes Drug Delivery Market Size YoY Growth 2016-2027
7.2 North America Liposomes Drug Delivery Market Facts & Figures by Country
7.2.1 North America Liposomes Drug Delivery Sales by Country (2016-2021)
7.2.2 North America Liposomes Drug Delivery Revenue by Country (2016-2021)
7.2.3 U.S.
7.2.4 Canada
8 Asia Pacific
8.1 Asia Pacific Liposomes Drug Delivery Market Size YoY Growth 2016-2027
8.2 Asia Pacific Liposomes Drug Delivery Market Facts & Figures by Region
8.2.1 Asia Pacific Liposomes Drug Delivery Sales by Region (2016-2021)
8.2.2 Asia Pacific Liposomes Drug Delivery Revenue by Region (2016-2021)
8.2.3 China
8.2.4 Japan
8.2.5 South Korea
8.2.6 India
8.2.7 Australia
8.2.8 Australia
8.2.9 Indonesia
8.2.10 Thailand
8.2.11 Malaysia
9 Europe
9.1 Europe Liposomes Drug Delivery Market Size YoY Growth 2016-2027
9.2 Europe Liposomes Drug Delivery Market Facts & Figures by Country
9.2.1 Europe Liposomes Drug Delivery Sales by Country (2016-2021)
9.2.2 Europe Liposomes Drug Delivery Revenue by Country (2016-2021)
9.2.3 Germany
9.2.4 France
9.2.5 U.K.
9.2.6 Italy
10 Latin America
10.1 Latin America Liposomes Drug Delivery Market Size YoY Growth 2016-2027
10.2 Latin America Liposomes Drug Delivery Market Facts & Figures by Country
10.2.1 Latin America Liposomes Drug Delivery Sales by Country (2016-2021)
10.2.2 Latin America Liposomes Drug Delivery Revenue by Country (2016-2021)
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Liposomes Drug Delivery Market Size YoY Growth 2016-2027
11.2 Middle East and Africa Liposomes Drug Delivery Market Facts & Figures by Country
11.2.1 Middle East and Africa Liposomes Drug Delivery Sales by Country (2016-2021)
11.2.2 Middle East and Africa Liposomes Drug Delivery Revenue by Country (2016-2021)
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 UAE
12 Company Profiles
12.1 Johnson & Johnson
12.1.1 Johnson & Johnson Corporation Information
12.1.2 Johnson & Johnson Description and Business Overview
12.1.3 Johnson & Johnson Liposomes Drug Delivery Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Johnson & Johnson Liposomes Drug Delivery Products Offered
12.1.5 Johnson & Johnson Recent Development
12.2 Gilead Sciences
12.2.1 Gilead Sciences Corporation Information
12.2.2 Gilead Sciences Description and Business Overview
12.2.3 Gilead Sciences Liposomes Drug Delivery Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Gilead Sciences Liposomes Drug Delivery Products Offered
12.2.5 Gilead Sciences Recent Development
12.3 Pacira
12.3.1 Pacira Corporation Information
12.3.2 Pacira Description and Business Overview
12.3.3 Pacira Liposomes Drug Delivery Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Pacira Liposomes Drug Delivery Products Offered
12.3.5 Pacira Recent Development
12.4 Sun Pharmaceutical
12.4.1 Sun Pharmaceutical Corporation Information
12.4.2 Sun Pharmaceutical Description and Business Overview
12.4.3 Sun Pharmaceutical Liposomes Drug Delivery Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Sun Pharmaceutical Liposomes Drug Delivery Products Offered
12.4.5 Sun Pharmaceutical Recent Development
12.5 Luye Pharma
12.5.1 Luye Pharma Corporation Information
12.5.2 Luye Pharma Description and Business Overview
12.5.3 Luye Pharma Liposomes Drug Delivery Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Luye Pharma Liposomes Drug Delivery Products Offered
12.5.5 Luye Pharma Recent Development
12.6 Sigma-Tau Group
12.6.1 Sigma-Tau Group Corporation Information
12.6.2 Sigma-Tau Group Description and Business Overview
12.6.3 Sigma-Tau Group Liposomes Drug Delivery Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Sigma-Tau Group Liposomes Drug Delivery Products Offered
12.6.5 Sigma-Tau Group Recent Development
12.7 Fudan-Zhangjiang
12.7.1 Fudan-Zhangjiang Corporation Information
12.7.2 Fudan-Zhangjiang Description and Business Overview
12.7.3 Fudan-Zhangjiang Liposomes Drug Delivery Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Fudan-Zhangjiang Liposomes Drug Delivery Products Offered
12.7.5 Fudan-Zhangjiang Recent Development
12.8 Teva Pharmaceutical
12.8.1 Teva Pharmaceutical Corporation Information
12.8.2 Teva Pharmaceutical Description and Business Overview
12.8.3 Teva Pharmaceutical Liposomes Drug Delivery Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Teva Pharmaceutical Liposomes Drug Delivery Products Offered
12.8.5 Teva Pharmaceutical Recent Development
12.9 CSPC
12.9.1 CSPC Corporation Information
12.9.2 CSPC Description and Business Overview
12.9.3 CSPC Liposomes Drug Delivery Sales, Revenue and Gross Margin (2016-2021)
12.9.4 CSPC Liposomes Drug Delivery Products Offered
12.9.5 CSPC Recent Development
12.10 Novartis
12.10.1 Novartis Corporation Information
12.10.2 Novartis Description and Business Overview
12.10.3 Novartis Liposomes Drug Delivery Sales, Revenue and Gross Margin (2016-2021)
12.10.4 Novartis Liposomes Drug Delivery Products Offered
12.10.5 Novartis Recent Development
12.11 Johnson & Johnson
12.11.1 Johnson & Johnson Corporation Information
12.11.2 Johnson & Johnson Description and Business Overview
12.11.3 Johnson & Johnson Liposomes Drug Delivery Sales, Revenue and Gross Margin (2016-2021)
12.11.4 Johnson & Johnson Liposomes Drug Delivery Products Offered
12.11.5 Johnson & Johnson Recent Development
12.12 Spectrum Pharmaceuticals
12.12.1 Spectrum Pharmaceuticals Corporation Information
12.12.2 Spectrum Pharmaceuticals Description and Business Overview
12.12.3 Spectrum Pharmaceuticals Liposomes Drug Delivery Sales, Revenue and Gross Margin (2016-2021)
12.12.4 Spectrum Pharmaceuticals Products Offered
12.12.5 Spectrum Pharmaceuticals Recent Development
12.13 Shanghai New Asia
12.13.1 Shanghai New Asia Corporation Information
12.13.2 Shanghai New Asia Description and Business Overview
12.13.3 Shanghai New Asia Liposomes Drug Delivery Sales, Revenue and Gross Margin (2016-2021)
12.13.4 Shanghai New Asia Products Offered
12.13.5 Shanghai New Asia Recent Development
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Liposomes Drug Delivery Industry Trends
13.2 Liposomes Drug Delivery Market Drivers
13.3 Liposomes Drug Delivery Market Challenges
13.4 Liposomes Drug Delivery Market Restraints
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Liposomes Drug Delivery Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Global Liposomes Drug Delivery Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
Table 2. Major Manufacturers of Liposomal Doxorubicin
Table 3. Major Manufacturers of Liposomal Amphoteracin B
Table 4. Major Manufacturers of Liposomal Paclitaxel
Table 5. Major Manufacturers of Others
Table 6. Global Liposomes Drug Delivery Market Size Growth Rate by Application (2021-2027) & (K Vials)
Table 7. Global Liposomes Drug Delivery Market Size by Region (K Vials) & (US$ Million), 2016 VS 2021 VS 2027
Table 8. Global Liposomes Drug Delivery Sales by Regions (2016-2021) & (K Vials)
Table 9. Global Liposomes Drug Delivery Sales Market Share by Regions (2016-2021)
Table 10. Global Liposomes Drug Delivery Revenue by Regions (2016-2021) & (US$ Million)
Table 11. Global Liposomes Drug Delivery Sales Forecast by Region (2022-2027) & (K Vials)
Table 12. Global Liposomes Drug Delivery Sales Market Share Forecast by Region (2022-2027)
Table 13. Global Liposomes Drug Delivery Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 14. Global Liposomes Drug Delivery Revenue Market Share Forecast by Region (2022-2027)
Table 15. Global Liposomes Drug Delivery Sales by Manufacturers (2016-2021) (K Vials)
Table 16. Global Liposomes Drug Delivery Sales Share by Manufacturers (2016-2021)
Table 17. Ranking of Global Top Liposomes Drug Delivery Manufacturers by Revenue (US$ Million) in 2020
Table 18. Liposomes Drug Delivery Revenue by Manufacturers (2016-2021) (US$ Million)
Table 19. Liposomes Drug Delivery Revenue Share by Manufacturers (2016-2021)
Table 20. Global Liposomes Drug Delivery Manufacturers Market Concentration Ratio (CR5 and HHI) & (2016-2021)
Table 21. Global Liposomes Drug Delivery by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Liposomes Drug Delivery as of 2020)
Table 22. Key Manufacturers Liposomes Drug Delivery Price (2016-2021) (USD/Vial)
Table 23. Liposomes Drug Delivery Manufacturers Manufacturing Base Distribution and Headquarters
Table 24. Manufacturers Liposomes Drug Delivery Product Type
Table 25. Date of International Manufacturers Enter into Liposomes Drug Delivery Market
Table 26. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 27. Global Liposomes Drug Delivery Sales by Type (2016-2021) (K Vials)
Table 28. Global Liposomes Drug Delivery Sales Share by Type (2016-2021)
Table 29. Global Liposomes Drug Delivery Revenue by Type (2016-2021) (US$ Million)
Table 30. Global Liposomes Drug Delivery Revenue Share by Type (2016-2021)
Table 31. Liposomes Drug Delivery Average Selling Price (ASP) by Type (2016-2021) & (USD/Vial)
Table 32. Global Liposomes Drug Delivery Sales Forecast by Type (2022-2027) & (K Vials)
Table 33. Global Liposomes Drug Delivery Sales Market Share Forecast by Type (2022-2027)
Table 34. Global Liposomes Drug Delivery Revenue Forecast V (2022-2027) & (US$ Million)
Table 35. Global Liposomes Drug Delivery Revenue Market Share Forecast by Type (2022-2027)
Table 36. Global Liposomes Drug Delivery Average Selling Price (ASP) Forecast by Type (2022-2027) & (USD/Vial)
Table 37. Global Liposomes Drug Delivery Sales by Application (2016-2021) (K Vials)
Table 38. Global Liposomes Drug Delivery Sales Share by Application (2016-2021)
Table 39. Global Liposomes Drug Delivery Revenue by Application (2016-2021) (US$ Million)
Table 40. Global Liposomes Drug Delivery Revenue Share by Application (2016-2021)
Table 41. Liposomes Drug Delivery Average Selling Price (ASP) by Application (2016-2021) & (USD/Vial)
Table 42. Global Liposomes Drug Delivery Sales Forecast by Application (2022-2027) & (K Vials)
Table 43. Global Liposomes Drug Delivery Sales Market Share Forecast by Application (2022-2027)
Table 44. Global Liposomes Drug Delivery Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 45. Global Liposomes Drug Delivery Revenue Market Share Forecast by Application (2022-2027)
Table 46. Global Liposomes Drug Delivery Average Selling Price (ASP) Forecast by Application (2022-2027) & (USD/Vial)
Table 47. China Liposomes Drug Delivery Sales (K Vials) of Key Companies (2016-2021)
Table 48. China Liposomes Drug Delivery Sales Share by Company (2016-2021)
Table 49. China Liposomes Drug Delivery Revenue (US$ Million) by Company (2016-2021)
Table 50. China Liposomes Drug Delivery Revenue Share by Company (2016-2021)
Table 51. China Liposomes Drug Delivery Sales (K Vials) by Type (2016-2021)
Table 52. China Liposomes Drug Delivery Sales Share by Type (2016-2021)
Table 53. China Liposomes Drug Delivery Revenue (US$ Million) Market Share by Type (2016-2021)
Table 54. China Liposomes Drug Delivery Price (USD/Vial) by Type (2016-2021)
Table 55. China Liposomes Drug Delivery Sales (K Vials) by Type (2022-2027)
Table 56. China Liposomes Drug Delivery Sales Share by Type (2022-2027)
Table 57. China Liposomes Drug Delivery Revenue (US$ Million) Market Share by Type (2022-2027)
Table 58. China Liposomes Drug Delivery Revenue Share by Type (2022-2027)
Table 59. China Liposomes Drug Delivery Price (USD/Vial) by Type (2022-2027)
Table 60. China Liposomes Drug Delivery Sales (K Vials) by Application (2016-2021)
Table 61. China Liposomes Drug Delivery Sales Share by Application (2016-2021)
Table 62. China Liposomes Drug Delivery Revenue (US$ Million) Market Share by Application (2016-2021)
Table 63. China Liposomes Drug Delivery Price (USD/Vial) by Application (2016-2021)
Table 64. China Liposomes Drug Delivery Sales (K Vials) by Application (2022-2027)
Table 65. China Liposomes Drug Delivery Sales Share by Application (2022-2027)
Table 66. China Liposomes Drug Delivery Revenue (US$ Million) Market Share by Application (2022-2027)
Table 67. China Liposomes Drug Delivery Revenue Share by Application (2022-2027)
Table 68. China Liposomes Drug Delivery Price (USD/Vial) by Application (2022-2027)
Table 69. North America Liposomes Drug Delivery Sales by Country (2016-2021) & (K Vials)
Table 70. North America Liposomes Drug Delivery Sales Market Share by Country (2016-2021)
Table 71. North America Liposomes Drug Delivery Revenue by Country (2016-2021) & (US$ Million)
Table 72. North America Liposomes Drug Delivery Revenue Market Share by Country (2016-2021)
Table 73. Asia Pacific Liposomes Drug Delivery Sales by Region (2016-2021) & (K Vials)
Table 74. Asia Pacific Liposomes Drug Delivery Sales Market Share by Region (2016-2021)
Table 75. Asia Pacific Liposomes Drug Delivery Revenue by Region (2016-2021) & (US$ Million)
Table 76. Asia Pacific Liposomes Drug Delivery Revenue Market Share by Region (2016-2021)
Table 77. Europe Liposomes Drug Delivery Sales by Country (2016-2021) & (K Vials)
Table 78. Europe Liposomes Drug Delivery Sales Market Share by Country (2016-2021)
Table 79. Europe Liposomes Drug Delivery Revenue by Country (2016-2021) & (US$ Million)
Table 80. Europe Liposomes Drug Delivery Revenue Market Share by Country (2016-2021)
Table 81. Latin America Liposomes Drug Delivery Sales by Country (2016-2021) & (K Vials)
Table 82. Latin America Liposomes Drug Delivery Sales Market Share by Country (2016-2021)
Table 83. Latin Americaa Liposomes Drug Delivery Revenue by Country (2016-2021) & (US$ Million)
Table 84. Latin America Liposomes Drug Delivery Revenue Market Share by Country (2016-2021)
Table 85. Middle East and Africa Liposomes Drug Delivery Sales by Country (2016-2021) & (K Vials)
Table 86. Middle East and Africa Liposomes Drug Delivery Sales Market Share by Country (2016-2021)
Table 87. Middle East and Africa Liposomes Drug Delivery Revenue by Country (2016-2021) & (US$ Million)
Table 88. Middle East and Africa Liposomes Drug Delivery Revenue Market Share by Country (2016-2021)
Table 89. Johnson & Johnson Corporation Information
Table 90. Johnson & Johnson Description and Business Overview
Table 91. Johnson & Johnson Liposomes Drug Delivery Sales (K Vials), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2016-2021)
Table 92. Johnson & Johnson Liposomes Drug Delivery Product
Table 93. Johnson & Johnson Recent Development
Table 94. Gilead Sciences Corporation Information
Table 95. Gilead Sciences Description and Business Overview
Table 96. Gilead Sciences Liposomes Drug Delivery Sales (K Vials), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2016-2021)
Table 97. Gilead Sciences Product
Table 98. Gilead Sciences Recent Development
Table 99. Pacira Corporation Information
Table 100. Pacira Description and Business Overview
Table 101. Pacira Liposomes Drug Delivery Sales (K Vials), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2016-2021)
Table 102. Pacira Product
Table 103. Pacira Recent Development
Table 104. Sun Pharmaceutical Corporation Information
Table 105. Sun Pharmaceutical Description and Business Overview
Table 106. Sun Pharmaceutical Liposomes Drug Delivery Sales (K Vials), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2016-2021)
Table 107. Sun Pharmaceutical Product
Table 108. Sun Pharmaceutical Recent Development
Table 109. Luye Pharma Corporation Information
Table 110. Luye Pharma Description and Business Overview
Table 111. Luye Pharma Liposomes Drug Delivery Sales (K Vials), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2016-2021)
Table 112. Luye Pharma Product
Table 113. Luye Pharma Recent Development
Table 114. Sigma-Tau Group Corporation Information
Table 115. Sigma-Tau Group Description and Business Overview
Table 116. Sigma-Tau Group Liposomes Drug Delivery Sales (K Vials), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2016-2021)
Table 117. Sigma-Tau Group Product
Table 118. Sigma-Tau Group Recent Development
Table 119. Fudan-Zhangjiang Corporation Information
Table 120. Fudan-Zhangjiang Description and Business Overview
Table 121. Fudan-Zhangjiang Liposomes Drug Delivery Sales (K Vials), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2016-2021)
Table 122. Fudan-Zhangjiang Product
Table 123. Fudan-Zhangjiang Recent Development
Table 124. Teva Pharmaceutical Corporation Information
Table 125. Teva Pharmaceutical Description and Business Overview
Table 126. Teva Pharmaceutical Liposomes Drug Delivery Sales (K Vials), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2016-2021)
Table 127. Teva Pharmaceutical Product
Table 128. Teva Pharmaceutical Recent Development
Table 129. CSPC Corporation Information
Table 130. CSPC Description and Business Overview
Table 131. CSPC Liposomes Drug Delivery Sales (K Vials), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2016-2021)
Table 132. CSPC Product
Table 133. CSPC Recent Development
Table 134. Novartis Corporation Information
Table 135. Novartis Description and Business Overview
Table 136. Novartis Liposomes Drug Delivery Sales (K Vials), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2016-2021)
Table 137. Novartis Product
Table 138. Novartis Recent Development
Table 139. Kingond Pharm Corporation Information
Table 140. Kingond Pharm Description and Business Overview
Table 141. Kingond Pharm Liposomes Drug Delivery Sales (K Vials), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2016-2021)
Table 142. Kingond Pharm Product
Table 143. Kingond Pharm Recent Development
Table 144. Spectrum Pharmaceuticals Corporation Information
Table 145. Spectrum Pharmaceuticals Description and Business Overview
Table 146. Spectrum Pharmaceuticals Liposomes Drug Delivery Sales (K Vials), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2016-2021)
Table 147. Spectrum Pharmaceuticals Product
Table 148. Spectrum Pharmaceuticals Recent Development
Table 149. Shanghai New Asia Corporation Information
Table 150. Shanghai New Asia Description and Business Overview
Table 151. Shanghai New Asia Liposomes Drug Delivery Sales (K Vials), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2016-2021)
Table 152. Shanghai New Asia Product
Table 153. Shanghai New Asia Recent Development
Table 154. Liposomes Drug Delivery Market Trends
Table 155. Liposomes Drug Delivery Market Drivers
Table 156. Liposomes Drug Delivery Market Challenges
Table 157. Liposomes Drug Delivery Market Restraints
Table 158. Liposomes Drug Delivery Customers List
Table 159. Liposomes Drug Delivery Distributors List
Table 160. Research Programs/Design for This Report
Table 161. Key Data Information from Secondary Sources
Table 162. Key Data Information from Primary Sources
List of Figures
Figure 1. Liposomes Drug Delivery Product Picture
Figure 2. Global Liposomes Drug Delivery Sales Market Share by Type in 2020 & 2027
Figure 3. Liposomal Doxorubicin Product Picture
Figure 4. Liposomal Amphoteracin B Product Picture
Figure 5. Liposomal Paclitaxel Product Picture
Figure 6. Others Product Picture
Figure 7. Global Liposomes Drug Delivery Sales Market Share by Application in 2020 & 2027
Figure 8. Fungal Infection Therapy
Figure 9. Cancer & Tumor Therapy
Figure 10. Others
Figure 11. Liposomes Drug Delivery Report Years Considered
Figure 12. Global Liposomes Drug Delivery Market Size, (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Liposomes Drug Delivery Market Size 2016-2027 (US$ Million)
Figure 14. Global Liposomes Drug Delivery Sales 2016-2027 (K Vials)
Figure 15. Global Liposomes Drug Delivery Market Size Market Share by Region: 2021 Versus 2027
Figure 16. Global Liposomes Drug Delivery Sales Market Share by Region (2016-2021)
Figure 17. Global Liposomes Drug Delivery Sales Market Share by Region in 2020
Figure 18. Global Liposomes Drug Delivery Revenue Market Share by Region (2016-2021)
Figure 19. Global Liposomes Drug Delivery Revenue Market Share by Region in 2020
Figure 20. Global Liposomes Drug Delivery Sales Share by Manufacturer in 2020
Figure 21. The Top 10 and 5 Players Market Share by Liposomes Drug Delivery Revenue in 2020
Figure 22. Liposomes Drug Delivery Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 23. Global Liposomes Drug Delivery Sales Market Share by Type (2016-2021)
Figure 24. Global Liposomes Drug Delivery Sales Market Share by Type in 2020
Figure 25. Global Liposomes Drug Delivery Revenue Market Share by Type (2016-2021)
Figure 26. Global Liposomes Drug Delivery Revenue Market Share by Type in 2020
Figure 27. Global Liposomes Drug Delivery Sales Market Share by Application (2016-2021)
Figure 28. Global Liposomes Drug Delivery Sales Market Share by Application in 2020
Figure 29. Global Liposomes Drug Delivery Revenue Market Share by Application (2016-2021)
Figure 30. Global Liposomes Drug Delivery Revenue Market Share by Application in 2020
Figure 31. China Liposomes Drug Delivery Sales Growth Rate 2016-2027 (K Vials)
Figure 32. China Liposomes Drug Delivery Revenue Growth Rate 2016-2027 (US$ Million)
Figure 33. China Liposomes Drug Delivery Market Share in Global Market 2016-2027
Figure 34. China 5 and 10 Largest Liposomes Drug Delivery Players Market Share by Revenue in Liposomes Drug Delivery in 2020
Figure 35. China Liposomes Drug Delivery Revenue Share by Type (2016-2021)
Figure 36. China Liposomes Drug Delivery Revenue Growth Rate by Type in 2016 & 2020
Figure 37. China Liposomes Drug Delivery Revenue Share by Application (2016-2021)
Figure 38. China Liposomes Drug Delivery Revenue Growth Rate by Application in 2016 & 2020
Figure 39. North America Liposomes Drug Delivery Sales Growth Rate 2016-2021 (K Vials)
Figure 40. North America Liposomes Drug Delivery Revenue Growth Rate 2016-2021 (US$ Million)
Figure 41. North America Liposomes Drug Delivery Sales Market Share by Country in 2020
Figure 42. North America Liposomes Drug Delivery Revenue Market Share by Country in 2020
Figure 43. U.S. Liposomes Drug Delivery Sales Growth Rate (2016-2021) (K Vials)
Figure 44. U.S. Liposomes Drug Delivery Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. Canada Liposomes Drug Delivery Sales Growth Rate (2016-2021) (K Vials)
Figure 46. Canada Liposomes Drug Delivery Revenue Growth Rate (2016-2021) (US$ Million)
Figure 47. Europe Liposomes Drug Delivery Sales Growth Rate 2016-2021 (K Vials)
Figure 48. Europe Liposomes Drug Delivery Revenue Growth Rate 2016-2021 (US$ Million)
Figure 49. Europe Liposomes Drug Delivery Sales Market Share by Country in 2020
Figure 50. Europe Liposomes Drug Delivery Revenue Market Share by Country in 2020
Figure 51. Germany Liposomes Drug Delivery Sales Growth Rate (2016-2021) (K Vials)
Figure 52. Germany Liposomes Drug Delivery Revenue Growth Rate (2016-2021) (US$ Million)
Figure 53. France Liposomes Drug Delivery Sales Growth Rate (2016-2021) (K Vials)
Figure 54. France Liposomes Drug Delivery Revenue Growth Rate (2016-2021) (US$ Million)
Figure 55. U.K. Liposomes Drug Delivery Sales Growth Rate (2016-2021) (K Vials)
Figure 56. U.K. Liposomes Drug Delivery Revenue Growth Rate (2016-2021) (US$ Million)
Figure 57. Italy Liposomes Drug Delivery Sales Growth Rate (2016-2021) (K Vials)
Figure 58. Italy Liposomes Drug Delivery Revenue Growth Rate (2016-2021) (US$ Million)
Figure 59. Russia Liposomes Drug Delivery Sales Growth Rate (2016-2021) (K Vials)
Figure 60. Russia Liposomes Drug Delivery Revenue Growth Rate (2016-2021) (US$ Million)
Figure 61. Asia Pacific Liposomes Drug Delivery Sales Growth Rate 2016-2021 (K Vials)
Figure 62. Asia Pacific Liposomes Drug Delivery Revenue Growth Rate 2016-2021 (US$ Million)
Figure 63. Asia Pacific Liposomes Drug Delivery Sales Market Share by Region in 2020
Figure 64. Asia Pacific Liposomes Drug Delivery Revenue Market Share by Region in 2020
Figure 65. China Liposomes Drug Delivery Sales Growth Rate (2016-2021) (K Vials)
Figure 66. China Liposomes Drug Delivery Revenue Growth Rate (2016-2021) (US$ Million)
Figure 67. Japan Liposomes Drug Delivery Sales Growth Rate (2016-2021) (K Vials)
Figure 68. Japan Liposomes Drug Delivery Revenue Growth Rate (2016-2021) (US$ Million)
Figure 69. South Korea Liposomes Drug Delivery Sales Growth Rate (2016-2021) (K Vials)
Figure 70. South Korea Liposomes Drug Delivery Revenue Growth Rate (2016-2021) (US$ Million)
Figure 71. India Liposomes Drug Delivery Sales Growth Rate (2016-2021) (K Vials)
Figure 72. India Liposomes Drug Delivery Revenue Growth Rate (2016-2021) (US$ Million)
Figure 73. Australia Liposomes Drug Delivery Sales Growth Rate (2016-2021) (K Vials)
Figure 74. Australia Liposomes Drug Delivery Revenue Growth Rate (2016-2021) (US$ Million)
Figure 75. China Taiwan Liposomes Drug Delivery Sales Growth Rate (2016-2021) (K Vials)
Figure 76. China Taiwan Liposomes Drug Delivery Revenue Growth Rate (2016-2021) (US$ Million)
Figure 77. Indonesia Liposomes Drug Delivery Sales Growth Rate (2016-2021) (K Vials)
Figure 78. Indonesia Liposomes Drug Delivery Revenue Growth Rate (2016-2021) (US$ Million)
Figure 79. Thailand Liposomes Drug Delivery Sales Growth Rate (2016-2021) (K Vials)
Figure 80. Thailand Liposomes Drug Delivery Revenue Growth Rate (2016-2021) (US$ Million)
Figure 81. Malaysia Liposomes Drug Delivery Sales Growth Rate (2016-2021) (K Vials)
Figure 82. Malaysia Liposomes Drug Delivery Revenue Growth Rate (2016-2021) (US$ Million)
Figure 83. Latin America Liposomes Drug Delivery Sales Growth Rate 2016-2021 (K Vials)
Figure 84. Latin America Liposomes Drug Delivery Revenue Growth Rate 2016-2021 (US$ Million)
Figure 85. Latin America Liposomes Drug Delivery Sales Market Share by Country in 2020
Figure 86. Latin America Liposomes Drug Delivery Revenue Market Share by Country in 2020
Figure 87. Mexico Liposomes Drug Delivery Sales Growth Rate (2016-2021) (K Vials)
Figure 88. Mexico Liposomes Drug Delivery Revenue Growth Rate (2016-2021) (US$ Million)
Figure 89. Brazil Liposomes Drug Delivery Sales Growth Rate (2016-2021) (K Vials)
Figure 90. Brazil Liposomes Drug Delivery Revenue Growth Rate (2016-2021) (US$ Million)
Figure 91. Argentina Liposomes Drug Delivery Sales Growth Rate (2016-2021) (K Vials)
Figure 92. Argentina Liposomes Drug Delivery Revenue Growth Rate (2016-2021) (US$ Million)
Figure 93. Middle East and Africa Liposomes Drug Delivery Sales Growth Rate 2016-2021 (K Vials)
Figure 94. Middle East and Africa Liposomes Drug Delivery Revenue Growth Rate 2016-2021 (US$ Million)
Figure 95. Middle East and Africa Liposomes Drug Delivery Sales Market Share by Country in 2020
Figure 96. Middle East and Africa Liposomes Drug Delivery Revenue Market Share by Country in 2020
Figure 97. Turkey Liposomes Drug Delivery Sales Growth Rate (2016-2021) (K Vials)
Figure 98. Turkey Liposomes Drug Delivery Revenue Growth Rate (2016-2021) (US$ Million)
Figure 99. Saudi Arabia Liposomes Drug Delivery Sales Growth Rate (2016-2021) (K Vials)
Figure 100. Saudi Arabia Liposomes Drug Delivery Revenue Growth Rate (2016-2021) (US$ Million)
Figure 101. UAE Liposomes Drug Delivery Sales Growth Rate (2016-2021) (K Vials)
Figure 102. UAE Liposomes Drug Delivery Revenue Growth Rate (2016-2021) (US$ Million)
Figure 103. Liposomes Drug Delivery Value Chain
Figure 104. Channels of Distribution
Figure 105. Distributors Profiles
Figure 106. Bottom-up and Top-down Approaches for This Report
Figure 107. Data Triangulation
Figure 108. Key Executives Interviewed
リポソームドラッグデリバリーの世界市場 2020年 Market Overview The Liposome Drug Delivery market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization…- 新ドラッグデリバリーシステムの世界市場 2020年 Market Overview The Novel Drug Delivery Systems market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimiz…
- 鼻腔内ドラッグデリバリーデバイスの世界及び中国市場 Intranasal drug delivery system is a medical device used for the administration of drugs for the treatment of local diseases in the nose and paranasal sinus such as allergic and non-allergic rhinitis and sinusitis. Intranasal Drug Delivery Devices are medical devices used for drug delivery through n…
- 鼻腔内薬物送達デバイスの世界市場 2020年 Market Overview The Intranasal Drug Delivery Devices market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain op…
- バイオ医薬品ドラッグデリバリーデバイスの世界市場 2020年 Market Overview The global Biopharmaceutical Drug Delivery Devices market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Bioph…